Navidea Biopharmaceuticals, Inc. (NYSEMKT:NAVB)

CAPS Rating: 2 out of 5

Recs

0
Player Avatar pchop123 (79.54) Submitted: 11/27/2012 7:59:32 PM : Outperform Start Price: $2.56 NAVB Score: +5.69

Attractive entry point

Featured Broker Partners


Advertisement